269. AML Flashcards

1
Q

AML

  • define
  • epi
  • RF
  • CP
  • 5 prognostic factors
A

AML: clonal proliferation of immature myeloid precursors
Epi: older males (65yo median), poor survival (5% 5 year survival), rare in children but better survival
RF: prior hx of chemo, radiation (therapy related has WORSE PRoGNosis), heme malignancy (MDS, MPN); benzenee exposure, cigarette smoking; down syndrome, fanconi anemia
CP: General sx: fever, fatigue, night sweats; bone marrow failure: anemia, thrombocytopenia, neutropenia; extramedullary tissue infiltration (Gingiva, skin, renal, lung, CNS, orbit)
- Tumor Lysis Syndrome (hyperuricemia, hyperK, hypoCa, renal failure, arrythmia, hypoxia, dyspnea, AMS)
- Coag Abnormalities (DIC)

  1. Age
  2. Performance Status
  3. Hx of prior cytotoxic therapy or MDS
  4. Cytogenetics and gene mutations
  5. Leukocyte count at presentation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

AML Dx

  • morphology
  • immunophenotype
  • cytogenetics
A
Dx: >20% blasts in BM or PB
Morph: evidence of myeloid differentiation
- Auer Rods
- Cytochem: MPO+ or NSE+
BM: hypercellular sheets of blasts
IHC: CD34+, CD117+

Cytogenetics: >50% AML have abnormality, MOST IMPORTANT PREDICTOR OF OUTCOME

  1. Low Risk: Acute Promyelocytic Leukemia with t(15;17)/PML-RARA (blocks differentiation of immature cells): good prognosis, highest cure rate (All Trans Retinoic Acid, Arsenic Trioxide (ATO)), CP: DIC
    - in young pt
    - many auer rods, bilobed nuclei
  2. Cord Binding Factor AML
    - either t(8;21) or inv(16)
    - in young adults, GOOD prognosis
    - Kit mutation = higher risk of relapse
    - t(8;21) = large blasts with Auer rods
    - inv(16) = atypical eosinophils (blue cytoplasmic granules)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

AML: Molecular Alterations and Tx

  • what is the “two hit” pathogenesis paradigm
  • what are three gene mutations that are diagnostic in AML and two gene mutations that are prognostic?
  • tx
A

First hit: promotes proliferation (RTK genes)
Second hit: impairs differentiation (driver mutation)

Diagnostic:

  1. NPM1 - causes abnormal localization of NPM1 protein to cytoplasm, IMPROVES OUTCOMES
  2. CEBPA - favorable outcomes if double mutation
  3. RUNX1

Prognostic:

  1. FLT3 - WORSE outcomes (target tx with TKIs)
  2. KIT

Tx: induction chemotx with post-remission chemotx or HSC transplant (consider new targeted therapies)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly